Mitsui Chemicals, Inc. · TSE:4183

Mitsui Chemicals — Q3 FY2025 Earnings Presentation

40 slides from Mitsui Chemicals's earnings presentation, Feb 5, 2026

  1. Slide 1: Financial Summary: Results for 3rd Quarter of FY2025 & Outlook for FY2025

    Financial Summary Results for 3 rd Quarter of FY2025 & Outlook for FY2025 Mitsui Chemicals, Inc. <Remarks> February 5, 2026 FY2025 indicates the period from April 1, 2025 to March 31, 2026. This summary contains forward-looking statements about the future plans, strategies, belief and performance of

  2. Slide 2: Contents

    1. Executive Summary Contents 1)Executive Summary: 3Q FY2025 Earnings Announcement ・・・1 2)Executive Summary: 3Q FY2025 Financial Results (Operating Income before Special Items) ・・・2 3)Executive Summary: FY2025 Financial Outlook(Operating Income before Special Items) ・・・3 4)Executive Summary: Shareho

  3. Slide 3: 1. Executive Summary

    1. Executive Summary Copyright © 2026 Mitsui Chemicals, Inc.

  4. Slide 4: Executive Summary: 3Q FY2025 Earnings Announcement

    1) Executive Summary: 3Q FY2025 Earnings Announcement ➢ Sales in the specialty chemicals domains have been firm, led mainly by ICT solutions, resulting in operating income before special items of 83.0 billion yen for 1-3Q of FY2025. The full-year forecast is 124.0 billion yen, which remains unchange

  5. Slide 5: Executive Summary: 3Q FY2025 Financial Results

    2) Executive Summary: 3Q FY2025 Financial Results (Operating Income before Special Items) ➢ Entire Group: Operating income before special items decreased to 68.0 billion yen for 1-3Q of FY2025, down 7.8 billion yen (-10%) YoY. While ICT Solutions saw profit growth driven by firm sales, this was outw

  6. Slide 6: Executive Summary: FY2025 Financial Outlook

    3) Executive Summary: FY2025 Financial Outlook (Operating Income before Special Items) ➢ Entire Group: Operating income before special items is expected to be 103.0 billion yen in FY2025—an increase of 2.0 billion yen (+2%) YoY—which is down 7.0 billion yen from our previous outlook announced on Nov

  7. Slide 7: Shareholder Returns

    4) Shareholder Returns We will repurchase our own shares and cancel treasury shares to improve capital efficiency and enhance shareholder returns. Through this, we aim to improve our ROE, and ultimately our corporate value and P/B ratio. 160 Dividend increase150 +5yen/share ● Stock split (effective

  8. Slide 8: 1. Results for 3rd Quarter of FY2025

    1. Results for 3 rd Quarter of FY2025 (April 1, 2025 –December 31, 2025) In accordance with the organizational reform implemented on April 1, 2025, we have revised the segment to which Mitsui Chemicals Asahi Life Materials Co., Ltd. belong from Life & Healthcare Solutions to ICT Solutions as well as

  9. Slide 9: Trends of Key Market Indicators

    1) Trends of Key Market Indicators FY2025 FY2025 Outlook 4Q 3Q→ (changes from previous 3Q Outlook 4Q outlook on Nov 11) Ophthalmic lens materials market Firm demand Firm demand expected Unchanged Life & Healthcare Solutions Firm demand expected; inventory level Firm demand; inventory level Agrochemi

  10. Slide 10: Major Investment Projects, etc.

    2) Major Investment Projects, etc. Major Investment projects Date Capacity FY23 FY24 FY25 FY26~ Life & Capacity expansion of MR™ High Refractive Index Ophthalmic Lens Material@Japan January.'24 - Capacity expansion of MR™ High Refractive Index Ophthalmic Lens Material@Japan Healthcare (Announced on

  11. Slide 11: Consolidated Financial Highlights

    3-1) Consolidated Financial Highlights (Billions of Yen) () Denotes a minus FY2024 FY2025 Increase Items % 1-3Q 1-3Q (Decrease) Sales revenue 1,338.8 1,218.7 (120.1) (9%) Operating income before special items 75.8 68.0 (7.8) (10%) (inc. Equity in earnings) 8.8 13.9 5.1 58% Non-recurring items (8.9)

  12. Slide 12: Consolidated Financial Highlights (Operating Income before Special Items)

    3-2) Consolidated Financial Highlights (Operating Income before Special Items) Comments Factors Main factors contributing to the increase[+] Main factors contributing to the decrease[-] ・Vision care materials increased due to firm demand. ・Agrochemicals increased due to firm demand mainly in the dom

  13. Slide 13: Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (compared with corresponding period of FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2024 FY2025 Incr. FY2024 FY2025 Incr. Terms of Volume Cos

  14. Slide 14: Life & Healthcare Solutions: Business Overview

    5-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Business Overview of FY25.1-3Q Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to

  15. Slide 15: Mobility Solutions: Business Overview

    5-2) Mobility Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Business Overview of FY25.1-3Q Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the incr

  16. Slide 16: ICT Solutions: Business Overview

    5-3) ICT Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Business Overview of FY25.1-3Q Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the increase[

  17. Slide 17: Basic & Green Materials: Business Overview

    5-4) Basic & Green Materials: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Business Overview of FY25.1-3Q Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the

  18. Slide 18: Sales Revenue and Operating Income by Business Segment (3Q)

    6) Sales Revenue and Operating Income before Special Items by Business Segment (compared with 3Q FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Segment FY2024 FY2025 Incr. FY2024 FY2025 Incr. Key factors behind increases and decreases 3Q 3Q (

  19. Slide 19: Non-recurring Items

    7) Non-recurring Items (Billions of Yen) () Denotes a minus FY2024 FY2025 Incr. Items Comments 1-3Q 1-3Q (Decr.) 25.1-3Q Impairment loss (6.5) (10.4) (3.9) Transfer of Equity Interest of PH business joint venture@China* -7.9 25.1-3Q Loss on related business ー (2.9) (2.9) Business restructuring: Kulz

  20. Slide 20: Consolidated Statement of Financial Position

    8) Consolidated Statement of Financial Position (Billions of Yen) () Denotes a minus End of End of Incr. End of End of Incr. Items Items Mar.2025 Dec.2025 (Decr.) Mar.2025 Dec.2025 (Decr.) Current assets 1,041.2 1,015.2 (26.0) Liabilities 1,183.4 1,203.9 20.5 Cash and cash equivalents 170.6 192.2 21

  21. Slide 21: Consolidated Statement of Cash Flows

    9) Consolidated Statement of Cash Flows (Billions of Yen) () Denotes a minus FY2024 FY2025 Incr. Items 1-3Q 1-3Q (Decr.) Ⅰ.Cash flows from operating activities (a) 141.4 141.0 (0.4) ( of which Working capital ) 7.8 48.2 40.4 Ⅱ.Cash flows from investing activities (b) (80.8) (97.0) (16.2) ( of which

  22. Slide 22: 3. Outlook for FY2025

    3. Outlook for FY2025 (April 1, 2025 – March 31, 2026) In accordance with the organizational reform implemented on April 1, 2025, we have revised the segment to which Mitsui Chemicals Asahi Life Materials Co., Ltd. belong from Life & Healthcare Solutions to ICT Solutions as well as that of certain o

  23. Slide 23: Highlights of Consolidated Financial Outlook

    1-1) Highlights of Consolidated Financial Outlook (Billions of Yen) () Denotes a minus FY2025 FY2025 Previous FY2024 Incr.(Decr.) Outlook Outlook Items (on Nov 11) 1st Half Full Year 1st Half Full Year Full Year % Full Year Sales revenue 890.4 1,809.2 813.6 1,675.0 (134.2) (7%) 1,700.0 Operating inc

  24. Slide 24: Highlights of Consolidated Financial Outlook (Operating Income before Special Items)

    1-2) Highlights of Consolidated Financial Outlook (Operating Income before Special Items) Comments Factors Main factors contributing to the increase[+] Main factors contributing to the decrease[-] ・Vision care materials expected to increase on the back of firm demand. ・Agrochemicals expected to incr

  25. Slide 25: Basic & Green Materials: Temporary factors and restructuring benefits in FY25

    2) Basic & Green Materials: Temporary factors and restructuring benefits in FY25 ⚫ Benefits from the restructuring of businesses implemented in FY25 have steadily materialized from 2Q onward, improving losses from these businesses which were approximately 3.0 billion yen in 1Q before the restructuri

  26. Slide 26: Sales Revenue and Operating Income of Outlook by Business Segment

    3) Sales Revenue and Operating Income before Special Items of Outlook by Business Segment (compared with FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2025 FY2025 Terms of FY2024 Incr.(Decr.) FY2024 Incr.(Decr.) Volume Co

  27. Slide 27: Life & Healthcare Solutions: Business Overview (Outlook)

    4-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview (compared with FY2024 results) Business Overview of FY25 (Outlook): Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the increase[+] M

  28. Slide 28: Mobility Solutions: Business Overview (Outlook)

    4-2) Mobility Solutions: Operating Income before Special Items and Business Overview (compared with FY2024 results) Business Overview of FY25 (Outlook): Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the increase[+] Main facto

  29. Slide 29: ICT Solutions: Business Overview (Outlook)

    4-3) ICT Solutions: Operating Income before Special Items and Business Overview (compared with FY2024 results) Business Overview of FY25 (Outlook): Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the increase[+] Main factors co

  30. Slide 30: Basic & Green Materials: Business Overview (Outlook)

    4-4) Basic & Green Materials: Operating Income before Special Items and Business Overview (compared with FY2024 results) Business Overview of FY25 (Outlook): Comments Movement of Operating Income before Special Items [+] denotes profit trigger Trend Main factors contributing to the increase[+] Main

  31. Slide 31: Operating Income before Special Items by Business Segment

    5) Operating Income before Special Items by Business Segment (compared with results of FY2024 2H / 4Q Outlook vs 3Q of FY2025) (Billions of Yen) () Denotes a minus () Denotes a minus Operating income before special items FY24 Comments 3Q→4Q Comments 2H YoY FY2025 Segment 4Q 2H [+] denotes profit tri

  32. Slide 32: Consolidated Statement of Cash Flows (Outlook)

    6) Consolidated Statement of Cash Flows (Billions of Yen) () Denotes a minus FY2025 FY2024 Outlook Items Incr.(Decr.) 1st Half Full Year(a) 1st Half Full Year(b) Ⅰ.Cash flows from operating activities (a) 118.0 200.5 127.2 200.0 (0.5) Ⅱ.Cash flows from investing activities (b) (48.3) (165.0) (57.6)

  33. Slide 33: 4. Appendix

    4. Appendix 1) Trends in Product Prices 2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment 3) Sales Revenue and Operating Income before Special Items by Business Segment 4) Outline of Business Segments 5) Data Highlights Copyright © 2026 Mitsui Chemicals, Inc.

  34. Slide 34: Trends in Product Prices

    1) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan): Change in Prices and Raw Materials Prices in Japan / TDI: Chinese Market Price) (ACP) : Asian contract price Year 2023 2024 2025 Month Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec. Jan.-Mar. Apr.-Jun

  35. Slide 35: Sales Revenue Increase/Decrease (Year on Year) by Business Segment

    2)Sales Revenue Increase/Decrease(Year on Year)by Business Segment (Billions of Yen) () Denotes a minus Sales revenue Breakdown Segment FY2024 FY2025 Comments Incr.(Decr.) Volume Prices 1-3Q 1-3Q Life & Healthcare Volume)Sales of vision care and domestic agrochemicals were firm.[+] 172.8 174.1 1.3 6

  36. Slide 36: Sales Revenue and Operating Income by Business Segment

    3) Sales Revenue and Operating Income before Special Items by Business Segment (Billions of Yen) () Denotes a minus Sales revenue* FY2024 FY2025 Segment Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Outlook Life & Healthcare Solutions 56.6 58.9 57.3 78.9 56.3 59.0 58.8 95.9 Mobilit

  37. Slide 37: Outline of Business Segments

    4) Outline of Business Segments Segment Businesses Main Products Vision Care Materials, Ophthalmic lens materials (MR™, Do Green™), Personal Care Materials, Life & Healthcare Medical materials (taurine), Oral Care, Agrochemicals Solutions Oral care materials (restoratives, adhesives, digital equipme

  38. Slide 38: Data Highlights

    5-1) Data Highlights ~FY19:J-GAAP / FY20~:IFRS () Denotes a minus (Billions of Yen) Total Assets (Billions of Yen) 2,500 Net Sales/Sales Revenue 2,400 2,215.8 2,154.0 2,200 2,068.2 1,879.5 1,935.0 2,000 1,749.7 1,809.2 1,675.0 2,000 1,482.9 1,612.7 1,339.0 1,800 1,500 1,211.7 1,558.1 1,600 1,501.1 1

  39. Slide 39: Data Highlights: Capex, D&A, R&D, Net D/E Ratio

    5-2) Data Highlights ~FY19:J-GAAP / FY20~:IFRS (Billions of Yen) 250.0 Capital Expenditure (Billions of Yen) Depreciation & Amortization 207.1 185.7 150.0 200.0 168.0 145.2 154.0 *2 109.0 150.0 *1 92.1 95.2 99.8 93.2 100.0 76.6 84.2 100.0 76.3 61.9 49.5 52.1 50.0 50.0 0.0 0.0 '18 '19 '20 '21 '22 '23

  40. Slide 40: Chemistry for Sustainable World

    Chemistry for Sustainable World Challenge Diversity One Team Copyright © 2026 Mitsui Chemicals, Inc.

Mitsui Chemicals — Q3 FY2025 Earnings Presentation on 6ix